$8 BillionThe market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.
$26.79 - $38.75The lowest and highst price in the last 52 weeks.
2.49xThe price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.
$0.56 (1.77%)Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).
|Market Cap||$8 Billion|
|Enterprise Value||$16.3 Billion|
|Dividend Yield||$0.56 (1.77%)|
|1 Year Return||-3.4%|
|Outstanding Shares||254 Million|
|Avg 30 Day Volume||2.4 Million|
|Earnings per Share||$12.66|
|Price to Sales Ratio||-|
|Price to Book Ratio||-4.24|
|Revenue to Enterprise Value||-|
|EBIT to Enterprise Value||-|
|Total Debt to Enterprise Value||0.57|
|Debt to Equity||-5.75|
|Quarterly Earnings Growth (YoY)||-|
|Return on Equity||-|
|Return on Assets||-|
|Return on Invested Capital||-|
3,000 shares bought (1 transactions)
Demars Financial Group LLC reduced its holdings in Organon & Co. (NYSE:OGN) by 28.2% during the third quarter, according to its most recent 13F filing with t...Dakota Financial News, 5 days ago
Jacobs & Co. CA decreased its position in shares of Organon & Co. (NYSE:OGN) by 18.3% during the third quarter, according to its most recent disclosure with ...Transcript Daily, 9 days ago
Kwhen Finance, 11 days ago
Carroll Financial Associates Inc. acquired a new position in Organon & Co. (NYSE:OGN) in the 3rd quarter, according to its most recent 13F filing with the Se...Dakota Financial News, 13 days ago